Syntensor is building software that converts large biological datasets into decisions. To predict clinical trial outcomes, the Syntensor platform first simulates a comprehensive suite of potency and ADMET assays; collectively, these two areas account for 60-70% of clinical trial failures. The model considers these predictions along with the burden of evidence for the drug's mechanism of action in the disease and trial design features to predict a probability of progression from one clinical trial stage to the next.
| Website | https://www.syntensor.com |
| Employees | 11 (8 on RocketReach) |
| Address | 6 Montgomery St, San Francisco, California 94104, US |
| Industry | Biotechnology Research |
| Keywords | Drug Discovery Platform, Drug Development, Human Physiology, Disease Modeling, Computational Biology, Systems Biology, Causal Inference, In Silico Modeling, Precision Medicine, Pharmacology, Toxicology, Bioinformatics, Mathematical Modeling, Complex Systems |
| Competitors | Google, Databricks, SAS, IBM, DataRobot, Alteryx, H2O.ai, Kaggle, Data Science Leaders Podcast, Altair RapidMiner +43 more (view full list) |
Looking for a particular Syntensor employee's phone or email?
Clayton Rabideau is the Founder, CEO of Syntensor.
8 people are employed at Syntensor.
Syntensor is based in San Francisco, California.